The role of CD103 (αEβ7 integrin) and other adhesion molecules in lymphocyte migration to organ allografts

Current Opinion in Organ Transplantation

Volumn 8, Issue 1, 2003, Pages 49-54

  El Asady, Riham S ^a   Yuan, Rongwen ^a   Hadley, Gregg A ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8344254184     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/00075200-200303000-00010     Document Type: Review

References (63)

1. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 1996, 272:60-66.
2. Picker LJ, Butcher EC: Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1992, 10:561-591.
3. Alon R, Kassner PD, Carr MW, et al.: The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 1995, 128:1243-1253.
4. Berlin C, Bargatze RF, Campbell JJ, et al.: alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995, 80:413-422.
5. DeGrendele HC, Estess P, Picker LJ, et al.: CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte- endothelial cell primary adhesion pathway. J Exp Med 1996, 183:1119-1130.
6. Bargatze RF, Butcher EC: Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules. J Exp Med 1993, 178:367-372.
7. Campbell DJ, Butcher EC: Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med 2002, 195:135-141.
8. Imhof BA, Dunon D: Leukocyte migration and adhesion. Adv Immunol 1995, 58:345-416.
9. Mobley JL, Dailey MO: Regulation of adhesion molecule expression by CD8 T cells in vivo. I. Differential regulation of gp90MEL-14 (LECAM-1), Pgp-1, LFA-1, and VLA-4 alpha during the differentiation of cytotoxic T lymphocytes induced by allografts. J Immunol 1992, 148:2348-2356.
10. Lollo BA, Chan KW, Hanson EM, et al.: Direct evidence for two affinity states for lymphocyte function-associated antigen 1 on activated T cells. J Biol Chem 1993, 268:21693-21700.
11. van Kooyk Y, van de Wiel-van Kemenade P, Weder P, et al.: Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 1989, 342:811-813.
12. Coito AJ, Kupiec-Weglinski JW: Extracellular matrix proteins in organ transplantation. Transplantation 2000, 69:2465-2473.
13. Ascher NL, Chen S, Hoffman RA, et al.: Maturation of cytotoxic T cells within sponge matrix allografts. J Immunol 1983, 131:617-621.
14. Solez K, Racusen LC, Abdulkareem F, et al.: Adhesion molecules and rejection of renal allografts. Kidney Int 1997, 51:1476-1480.
15. Fries JW, Williams AJ, Atkins RC, et al.: Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol 1993, 143:725-737.
16. Weis M, von Scheidt W: Cardiac allograft vasculopathy: a review. Circulation 1997, 96:2069-2077.
17. Shimizu A, Colvin RB, Yamanaka N: Rejection of peritubular capillaries in renal allo- and xeno-graft. Clin Transplant 2000, 14 Suppl 3:6-14.
18. Hemler ME: VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990, 8:365-400.
19. Steinmuller D: Which T cells mediate allograft rejection? Transplantation 1985, 40:229-233.
20. Hall BM: Cells mediating allograft rejection. Transplantation 1991, 51:1141-1151.
21. Robertson H, Wheeler J, Kirby JA, et al.: Renal allograft rejection-in situ demonstration of cytotoxic intratubular cells. Transplantation 1996, 61:1546-1549.
22. Solez K: International standardization in renal allograft biopsy reporting: a model for a new approach to renal pathology. Nephrol Dial Transplant 1994, 9 Suppl 4:157-158.
23. Hadley GA, Bartlett ST, Via CS, et al.: The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL. J Immunol 1997, 159:3748-3756.
24. Hadley GA, Rostapshova EA, Gomolka DM, et al.: Regulation of the epithelial cell-specific integrin, CD103, by human CD8+ cytolytic T lymphocytes. Transplantation 1999, 67:1418-1425.
25. Rostapshova EA, Burns JM, Bartlett ST, et al.: Integrin-mediated interactions influence the tissue specificity of CD8+ cytolytic T lymphocytes. Eur J Immunol 1998, 28:3031-3039.
26. Karecla PI, Bowden SJ, Green SJ, et al.: Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7). Eur J Immunol 1995, 25:852-856.
27. Lefrancois L, Parker CM, Olson S, et al.: The role of beta7 integrins in CD8 T cell trafficking during an antiviral immune response. J Exp Med 1999, 189:1631-1638.
28. Aberle H, Schwartz H, Kemler R: Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem 1996, 61:514-523.
29. Kilshaw PJ, Baker KC: A unique surface antigen on intraepithelial lymphocytes in the mouse. Immunol Lett 1988, 18:149-154.
30. Kilshaw PJ, Murant SJ: A new surface antigen on intraepithelial lymphocytes in the intestine. Eur J Immunol 1990, 20:2201-2207.
31. Cerf-Bensussan N, Jarry A, Brousse N, et al.: A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 1987, 17:1279-1285.
32. Kilshaw PJ, Murant SJ: Expression and regulation of beta 7(beta p) integrins on mouse lymphocytes: relevance to the mucosal immune system. Eur J Immunol 1991, 21:2591-2597.
33. Kilshaw PJ: Alpha E beta 7. Mol Pathol 1999, 52:203-207.
34. Rihs S, Walker C, Virchow JC, Jr, et al.: Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta. Am J Respir Cell Mol Biol 1996, 15:600-610.
35. Roberts K, Kilshaw PJ: The mucosal T cell integrin alpha M290 beta 7 recognizes a ligand on mucosal epithelial cell lines. Eur J Immunol 1993, 23:1630-1635.
36. Cepek KL, Shaw SK, Parker CM, et al.: Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 1994, 372:190-193.
37. Higgins JM, Mandlebrot DA, Shaw SK, et al.: Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin. J Cell Biol 1998, 140:197-210.
38. Sarnacki S, Begue B, Buc H, et al.: Enhancement of CD3-induced activation of human intestinal intraepithelial lymphocytes by stimulation of the beta 7-containing integrin defined by HML-1 monoclonal antibody. Eur J Immunol 1992, 22:2887-2892.
39. Russell GJ, Parker CM, Cepek KL, et al.: Distinct structural and functional epitopes of the alpha E beta 7 integrin. Eur J Immunol 1994, 24:2832-2841.
40. Lefrancois L, Barrett TA, Havran WL, et al.: Developmental expression of the alpha IEL beta 7 integrin on T cell receptor gamma delta and T cell receptor alpha beta T cells. Eur J Immunol 1994, 24:635-640.
41. Schon MP, Arya A, Murphy EA, et al.: Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol 1999, 162:6641-6649.
42. Robertson H, Wong WK, Talbot D, et al.: Tubulitis after renal transplantation: demonstration of an association between CD103+ T cells, transforming growth factor beta1 expression and rejection grade. Transplantation 2001, 71:306-313.
43. Hadley GA, Charandee C, Weir MR, et al.: CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection. Transplantation 2001, 72:1548-1555.
44. Feng Y WD, Yuan R, Parker CM, et al.: CD103 expression is required for destruction of pancreatic islet allografts by CD8+ T cells. J Exp Med 2002, 196.
45. Cirulli V, Baetens D, Rutishauser U, et al.: Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation. J Cell Sci 1994, 107 ( Pt 6):1429-1436.
46. Lucas PJ, Kim SJ, Melby SJ, et al.: Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J Exp Med 2000, 191:1187-1196.
47. Gorelik L, Flavell RA: Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2002, 2:46-53.
48. Pardoux C, Asselin-Paturel C, Chehimi J, et al.: Functional interaction between TGF-beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J Immunol 1997, 158:136-143.
49. Smyth MJ, Strobl SL, Young HA, et al.: Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. J Immunol 1991, 146:3289-3297.
50. Wahl SM: Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 1994, 180:1587-1590.
51. Shull MM, Ormsby I, Kier AB, et al.: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
52. Shihab FS, Tanner AM, Shao Y, et al.: Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int 1996, 50:1904-1913.
53. Leteurtre E, Copin MC, Labalette M, et al.: Negative immunohistochemical detection of CD103 (alphaEbeta7 integrin) in the infiltrates of acute rejection in liver and kidney transplantation. Transplantation 2000, 70:227-229.
54. Shihab FS, Yamamoto T, Nast CC, et al.: Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 1995, 6:286-294.
55. Vriens PW, Nisco SJ, Hoyt EG, et al.: Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats. Transplantation 1994, 57:1795-1798.
56. Mohamed MA, Robertson H, Booth TA, et al.: TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus. Transplantation 2000, 69:1002-1005.
57. Khanna A, Kapur S, Sharma V, et al.: In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine. Transplantation 1997, 63:1037-1039.
58. Pankewycz OG, Miao L, Isaacs R, et al.: Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Kidney Int 1996, 50:1634-1640.
59. Topham DJ, Tripp RA, Doherty PC: CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 1997, 159:5197-5200.
60. Barth RJ, Jr, Mule JJ, Spiess PJ, et al.: Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumorinfiltrating lymphocytes. J Exp Med 1991, 173:647-658.
61. Diamond AS, Gill RG: An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts. J Immunol 2000, 165:247-255.
62. Cocchi F, DeVico AL, Garzino-Demo A, et al.: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815.
63. Kim JJ, Nottingham LK, Sin JI, et al.: CD8 positive T cells influence antigenspecific immune responses through the expression of chemokines. J Clin Invest 1998, 102:1112-1124.